PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Blueberry extract could help fight gum disease and reduce antibiotic use

2015-09-02
(Press-News.org) Gum disease is a common condition among adults that occurs when bacteria form biofilms or plaques on teeth, and consequently the gums become inflamed. Some severe cases, called periodontitis, call for antibiotics. But now scientists have discovered that wild blueberry extract could help prevent dental plaque formation. Their report in ACS' Journal of Agricultural and Food Chemistry could lead to a new therapy for periodontitis and a reduced need for antibiotics.

Many people have had some degree of gum inflammation, or gingivitis, caused by dental plaque. The gums get red and swollen, and they bleed easily. If left unchecked, the condition can progress to periodontitis. The plaque hardens into tartar, and the infection can spread below the gum line and destroy the tissue supporting the teeth. To treat this condition, dentists scrape off the tartar and sometimes have to resort to conventional antibiotics. But recently, researchers have started looking at natural antibacterial compounds to treat gum disease. Daniel Grenier and colleagues wanted to see if blueberry polyphenols, which work against foodborne pathogens, could also help fight Fusobacterium nucleatum, one of the main species of bacteria associated with periodontitis.

In the lab, the researchers tested extracts from the wild lowbush blueberry, Vaccinium angustifolium Ait., against F. nucleatum. The polyphenol-rich extracts successfully inhibited the growth of F. nucleatum, as well as its ability to form biofilms. It also blocked a molecular pathway involved in inflammation, a key part of gum disease. The researchers say they're developing an oral device that could slowly release the extract after deep cleaning to help treat periodontitis.

INFORMATION:

The authors acknowledge funding from the Laboratoire de Contrôle Microbiologique de l'Université Laval

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us: Twitter Facebook



ELSE PRESS RELEASES FROM THIS DATE:

Evidence that Earth's first mass extinction was caused by critters not catastrophe

2015-09-02
NASHVILLE, Tenn. - In the popular mind, mass extinctions are associated with catastrophic events, like giant meteorite impacts and volcanic super-eruptions. But the world's first known mass extinction, which took place about 540 million years ago, now appears to have had a more subtle cause: evolution itself. "People have been slow to recognize that biological organisms can also drive mass extinction," said Simon Darroch, assistant professor of earth and environmental sciences at Vanderbilt University. "But our comparative study of several communities of Ediacarans, ...

New study reveals how changes in lifestyle are contributing to dramatic rise in obesity

2015-09-02
New research from Royal Holloway, University of London has found that changes in lifestyle over the past 30 years have led to a sharp reduction in the strenuousness of daily life, which researchers say may explain why there has been a dramatic rise in obesity. The study, carried out by Dr Melanie Luhrmann from the Department of Economics along with Professor Rachel Griffith and Dr Rodrigo Lluberas, revealed that while obesity rates have almost trebled, surprisingly, our actual calorie intake has fallen by around 20 per cent compared to 30 years ago. The researchers found ...

Silk bio-ink could help advance tissue engineering with 3-D printers

2015-09-02
Advances in 3-D printing have led to new ways to make bone and some other relatively simple body parts that can be implanted in patients. But finding an ideal bio-ink has stalled progress toward printing more complex tissues with versatile functions -- tissues that can be loaded with pharmaceuticals, for example. Now scientists, reporting in the journal ACS Biomaterials Science & Engineering, have developed a silk-based ink that could open up new possibilities toward that goal. Most inks currently being developed for 3-D printing are made of thermoplastics, silicones, ...

Struggles ahead in China for chemical and pharmaceutical companies

2015-09-02
China's economic downturn plus other factors, including overcapacity and tightening regulations, mean the next two to three years could be challenging for the foreign chemical and pharmaceutical companies located there. To survive in China as it adjusts to a slower pace of growth, businesses will likewise need to adapt, reports Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society. Jean-François Tremblay, a senior correspondent at C&EN, notes that owing to reforms initiated in 1978, China has been a profitable place for chemical ...

Study provides insights into the mechanisms of fine-tuning of wheat to diverse environments

Study provides insights into the mechanisms of fine-tuning of wheat to diverse environments
2015-09-02
MANHATTAN, Kansas -- A Kansas State University wheat geneticist is part of a breakthrough study that identifies one of the wheat genes that controls response to low temperature exposure, a process called vernalization. Natural variation in vernalization genes defines when the plant begins to flower and is critical for adaptation to different environments. Researchers anticipate this will help wheat breeders design wheat varieties that can adapt and thrive in changing environments around the world. Eduard Akhunov, associate professor in the plant pathology department, ...

Men in China face increasing tobacco-related cancer risks

2015-09-02
In China, smoking now causes nearly a quarter of all cancers in adult males. The finding comes from a large study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, as part of a Special Issue on Lung Cancer in China. High uptake rates of cigarette smoking in teenaged males and continued use in adulthood foreshadow even greater tobacco-related cancer risks for the nation. Tobacco-related deaths have been declining steadily in most developed countries; however, China now produces and consumes about 40 percent of the world's cigarettes, ...

The risk of cognitive impairment in children born prematurely may be predicted using MRI after birth

2015-09-02
School age children who are born prematurely are more likely to have low mathematical achievement, thought to be associated with reduced working memory and number skills, according to a new study published today in the neurology journal Brain. Researchers assessed up to 224 preterm children at age five and age seven to examine the use of magnetic resonance imaging (MRI) after birth to identify infants at risk of later academic impairment. The study participants are from Melbourne, Australia and are part of a Murdoch Children's Research Institute study. The authors suggest ...

Radioactive contaminants found in coal ash

Radioactive contaminants found in coal ash
2015-09-02
DURHAM, N.C. -- A new Duke University-led study has revealed the presence of radioactive contaminants in coal ash from all three major U.S. coal-producing basins. The study found that levels of radioactivity in the ash were up to five times higher than in normal soil, and up to 10 times higher than in the parent coal itself because of the way combustion concentrates radioactivity. The finding raises concerns about the environmental and human health risks posed by coal ash, which is currently unregulated and is stored in coal-fired power plants' holding ponds and landfills ...

Columbia Engineering team develops targeted drug delivery to lung

Columbia Engineering team develops targeted drug delivery to lung
2015-09-02
New York, NY--September 2, 2015--Researchers from Columbia Engineering and Columbia University Medical Center (CUMC) have developed a new method that can target delivery of very small volumes of drugs into the lung. Their approach, in which micro-liters of liquid containing a drug are instilled into the lung, distributed as a thin film in the predetermined region of the lung airway, and absorbed locally, may provide much more effective treatment of lung disease. The work was published in the August 31 online Early Edition of Proceedings of the National Academy of Sciences ...

Making fuel from light

2015-09-02
Refined by nature over a billion years, photosynthesis has given life to the planet, providing an environment suitable for the smallest, most primitive organism all the way to our own species. While scientists have been studying and mimicking the natural phenomenon in the laboratory for years, understanding how to replicate the chemical process behind it has largely remained a mystery -- until now. Recent experiments at the U.S. Department of Energy's Argonne National Laboratory have afforded researchers a greater understanding of how to manipulate photosynthesis, ...

LAST 30 PRESS RELEASES:

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

[Press-News.org] Blueberry extract could help fight gum disease and reduce antibiotic use